A detailed history of Barrett & Company, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Barrett & Company, Inc. holds 425 shares of DHR stock, worth $112,276. This represents 0.05% of its overall portfolio holdings.

Number of Shares
425
Previous 375 13.33%
Holding current value
$112,276
Previous $86.7 Million 22.37%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$224.58 - $256.19 $11,229 - $12,809
50 Added 13.33%
425 $106 Million
Q2 2023

Jul 27, 2023

BUY
$224.99 - $256.14 $13,274 - $15,112
59 Added 18.67%
375 $89.9 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $75,761 - $87,532
316 New
316 $79.5 Million
Q4 2022

May 23, 2023

SELL
$241.42 - $282.29 $241 - $282
-1 Reduced 0.32%
315 $83.7 Million
Q3 2022

Jun 13, 2023

SELL
$247.06 - $1507.4 $247 - $1,507
-1 Reduced 0.32%
315 $83.7 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $192B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Barrett & Company, Inc. Portfolio

Follow Barrett & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barrett & Company, Inc. with notifications on news.